Ye Xu

机构：Kunming University of Science and Technology, Second Affiliated Hospital of Guangzhou Medical University, Ministry of Education, Guangzhou Medical University · ORCID：0000-0002-5520-3839

发表论文 128 篇 · 总被引 2502 次 · h-index 28

代表论文

• BRCA-CRisk: A Contralateral Breast Cancer Risk Prediction Model for BRCA Carriers (2022 · Journal of Clinical Oncology · 被引 31)
• Tislelizumab in previously treated, locally advanced unresectable/metastatic microsatellite instability-high/mismatch repair-deficient solid tumors (2024 · Chinese Journal of Cancer Research · 被引 18)
• Prevalence of BRCA1 and BRCA2 pathogenic variants in 8627 unselected patients with breast cancer: stratification of age at diagnosis, family history and molecular subtype (2022 · Breast Cancer Research and Treatment · 被引 15)
• Ovarian cancer risk of Chinese women with BRCA1/2 germline pathogenic variants (2022 · Journal of Human Genetics · 被引 7)
• Impact of multifocal or multicentric disease on local recurrence and survival in breast cancer patients with or without BRCA1/2 variants (2023 · Breast Cancer Research and Treatment · 被引 6)
• Olaparib promotes FABP4 expression and reduces antitumor effect in ovarian cancer cells with a BRCA1 mutation (2024 · Oncology Letters · 被引 5)